» Articles » PMID: 14769576

Interpectoral Nodes As the Initial Site of Recurrence in Breast Cancer

Overview
Journal Arch Surg
Specialty General Surgery
Date 2004 Feb 11
PMID 14769576
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Hypothesis: Interpectoral nodes can be the initial site of recurrent breast cancer.

Design: Retrospective review.

Setting: Comprehensive breast center, located in a university-based tertiary care center.

Patients: All patients undergoing operations for breast cancer at our breast center from 1995 to 2002 were reviewed.

Main Outcome Measures: Patients with interpectoral node recurrence as the initial site of recurrent breast cancer were identified.

Results: During the 8-year period, 4097 patients underwent surgical management for breast cancer. During this time, 4 patients (0.1%) had recurrence at the interpectoral nodes. Three of the 4 patients were node-negative at the original operation. All lesions were mammographically occult. Preoperative needle biopsy was effective in the confirmation of malignancy. All 4 underwent excision without complications.

Conclusions: Recurrence at the interpectoral nodes can be the initial site of surgical failure. These nodes may represent the site of primary drainage in a percentage of patients. The sentinel node identification technique, therefore, should diminish the number of patients affected by recurrence at this site. In patients with a palpable mass in the infraclavicular location, however, a high index of suspicion should be maintained. Workup should include additional breast imaging and needle biopsy prior to operation.

Citing Articles

Interpectoral Lymph Node Dissection Can Be Spared in pN0/N1 Invasive Breast Cancer Undergoing Modified Radical Mastectomy: Single-Institution Experience from Mainland China.

Yan Y, Jiang L, Fang J, Dai Y, Chenyu X, Ding J Cancer Manag Res. 2021; 13:5855-5863.

PMID: 34349558 PMC: 8326277. DOI: 10.2147/CMAR.S313971.


Prognostic value of the interpectoral lymph nodes in breast cancer. A 20-year survival study.

Garcia-Vilanova Comas A, Garcia Vilanova A, Fuster-Diana E, Martinez-Alzamora N, Fernandez-Tena J, Garcia-Vilanova Comas J Clin Transl Oncol. 2006; 8(2):108-18.

PMID: 16632425 DOI: 10.1007/s12094-006-0167-9.


Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT.

Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E Eur J Nucl Med Mol Imaging. 2005; 33(3):329-37.

PMID: 16220303 DOI: 10.1007/s00259-005-1927-4.